← Back to Patent Explorer
US4738986A Expired / Lapsed US ⏱️ 0.0 years remaining

N-(3-phenoxycinnamyl)acetohydroxamic acid

Assignee: SmithKline Beecham Corp
•
Filing: 1987-03-10
•
Granted: 1988-04-19
•
Expires: 2007-03-10
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract Novel compounds of formula (I) Ar--(L--Ar').sub.q --(X).sub.k --(Y).sub.p --Q (I) wherein: k, p and q are independently 0 or 1; Ar represents either: (i) naphthyl, tetrahydronaphthyl, pyridyl or (ii) phenyl, optionally substituted, L is selected from --(CH 2 ) r -- (where r is 1-4), --O--, --CH 2 O--, --CH 2 S--, --OCH 2 --, --CONH--, --NHCO--, --CO-- and --CH 2 NH--, and, Ar' represents phenylene, thienylene or pyridylene optionally substituted, X represents oxygen, sulphur or carbonyl, Y is C 1-10 alkylene or C 1-10 alkenylene; Q represents a non-cyclic moiety selected from groups of formula ##STR1## in which one of m and n is 0 and the other is 1, R 1 and R 2 is selected from hydrogen, C 1-4 alkyl, amino, C 1-4 alkylamino, di-C 1-4 alkylamino, C 5-7 cycloalkylamino, C 5-7 cycloalkyl (C 1-4 alkyl) amino, anilino, N-C 1-4 alkylanilino or Q represents a cyclic moiety selected from 1-hydroxy-1,3-dihydroimidazol-2-one and groups of formula ##STR2## in which Z represents a C 2-5 alkylene chain in which one of the carbon atoms may be replaced by a hetero atom; and salts thereof.

Inventors

  • 👤 Geoffrey Kneen
  • 👤 William P. Jackson
  • 👤 Peter J. Islip
  • 👤 Peter J. Wates

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-11-08 06:27
CPC Classifications
C; C07; C07D; C07D213/00; C07D213/02; C07D213/04; C07D213/24; C07D213/28; C07D213/30; C07C; C07C275/00; C07C275/64; C07D207/00; C07D207/46; C07D213/36; C07D213/42; C07D213/60; C07D213/62; C07D213/63; C07D213/64; C07D213/643; C07D233/00; C07D233/04; C07D233/28; C07D233/44; C07D233/46; C07D279/00; C07D279/10; C07D279/12; C07D333/00; C07D333/02; C07D333/04; C07D333/06; C07D333/14; C07D333/16; C07D333/20; C07D401/00; C07D401/02; C07D401/04; C07D401/06

Claims Analysis

Total Claims: 11
Claim 1
Independent Claim 2 words
N-(3-phenoxycinnamyl)acetohydroxamic acid.
Claim 2
Dependent Claim 2 words
N-(3-phenoxycinnamyl)acetohydroxamic acid.
Claim 3
Dependent Claim 5 words
A salt of N-(3-phenoxycinnamyl)acetohydroxamic acid.
Claim 4
Dependent Claim 5 words
A salt of N-(3-phenoxycinnamyl)acetohydroxamic acid.
Claim 5
Dependent Claim 7 words
A physiologically acceptable salt of N-(3-phenoxycinnamyl)acetohydroxamic acid.
Claim 6
Dependent Claim 7 words
A physiologically acceptable salt of N-(3-phenoxycinnamyl)acetohydroxamic acid.
Claim 7
Dependent Claim 19 words
A pharmaceutical composition comprising N-(3-phenoxycinnamyl)acetohydroxyamic acid or a physiologically acceptable salt thereof together with a physiologically acceptable carrier therefor.
Claim 8
Dependent Claim 19 words
A pharmaceutical composition comprising N-(3-phenoxycinnamyl)acetohydroxyamic acid or a physiologically acceptable salt thereof together with a physiologically acceptable carrier therefor.
Claim 9
Independent Claim 30 words
A method of inhibiting lipoxigenase and cyclo-oxygenase enzymes in a mammal which comprises administering an effective inhibition amount of N-(3-phenoxycinnamyl)acetohydroxamic acid or a physiologically acceptable salt thereof to said mammal.
Claim 10
Independent Claim 30 words
A method of inhibiting lipoxigenase and cyclo-oxygenase enzymes in a mammal which comprises administering an effective inhibition amount of N-(3-phenoxycinnamyl)acetohydroxamic acid or a physiologically acceptable salt thereof to said mammal.
Claim 11
Dependent Claim 12 words
The method of claim 5 in which the mammal is a human.

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1991-04-19 1991-10-19 1992-04-19 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1995-04-19 1995-10-19 1996-04-19 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1999-04-19 1999-10-19 2000-04-19 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag